Search results
Results From The WOW.Com Content Network
Metoidioplasty, metaoidioplasty, or metaidoioplasty [2] (informally called a meto or meta) is a female-to-male gender-affirming surgery. [ 3 ] Testosterone replacement therapy gradually enlarges the clitoris to a mean maximum size of 4.6 cm (1.8 in) [ 4 ] (as the clitoris and the penis are developmentally homologous ).
Surgeries for female-to-male transgender patients have similarities to both gynecomastia surgeries for cisgender men, [2] breast reduction surgery for gigantomastia, and the separate mastectomies done for breast cancer. [3] Top surgery involves more than a mastectomy for the treatment of breast cancer. [1]
Cardiovascular risk factors are more than additive. (If high blood pressure is worth 10 and smoking is worth 10, together they are worth more than 20.) So for transgender men, the addition of risk with androgen therapy makes improving modifiable risk factors more important. The most important modifiable risk factor for many men is smoking.
The ICD-10 Procedure Coding System (ICD-10-PCS) is a US system of medical classification used for procedural coding.The Centers for Medicare and Medicaid Services, the agency responsible for maintaining the inpatient procedure code set in the U.S., contracted with 3M Health Information Systems in 1995 to design and then develop a procedure classification system to replace Volume 3 of ICD-9-CM.
Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.
It is composed of sterol cells, Leydig cells, or some combination of the two. The tumor can produce male or female hormones and may cause masculinization. In a prepubescent child, a tumor may cause precocious puberty. Malignant arrhenoblastoma accounts for 30% of cases of arrhenoblastoma, the other 70% being largely benign and curable with surgery.
Gender nullification is the removal of all external genitalia except the urethral opening, typically pursued by people assigned male at birth. [10] [medical citation needed] Gender-affirming surgery can also refer to operations pursued by cisgender people, such as mammaplasty, penile implant, or testicular implants following orchiectomy. [11]
People may pursue chest reconstruction, also known as top surgery, as part of transitioning. The removal of breast tissue in chest reconstruction is a type of mastectomy called a subcutaneous (under the skin) mastectomy.